Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥484m2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥1.8bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.3bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income−¥96m2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥111m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income−¥124m2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥268m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥238m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax−¥112m2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥291m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)−¥99m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥348m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥249m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income−¥99m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥251m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥8.5bnat 2023-09-30Cons.Assets
Total assets¥8.4bnat 2023-03-31Cons.Assets
Total assets¥8.4bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥594mat 2023-09-30Cons.Liabilities
Total liabilities¥426mat 2023-03-31Cons.Liabilities
Net assets / equity¥7.9bnat 2023-09-30Cons.Net assets
Net assets / equity¥8.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥7.9bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.9bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥3.0bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥2.9bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥3.0bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.6bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.8bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow−¥44m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥755m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥409m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥65m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥769m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥777m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥45m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥364m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥362m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-10.992023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.832023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.472022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.592022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.72022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio90.9%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio93.1%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio92.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥192m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥418m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥418m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥75m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥66m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥66m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥20m
—segment totalrevenue2023-04-01 → 2023-09-30¥484m
—segment totalrevenue external2023-04-01 → 2023-09-30¥484m
—segment totalsegment profit2023-04-01 → 2023-09-30¥95m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥484m
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥484m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥95m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥241m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥623m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥623m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥258m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥643m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥643m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥94m
—segment totalrevenue2022-04-01 → 2022-09-30¥1.3bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥1.3bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥353m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥353m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 530
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember2242600
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.2477
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember968800
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.1070
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember703300
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0777
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember243000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0268
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember242900
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0268
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember242156
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0267
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember230000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0254
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember194700
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0215
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember172400
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0190
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember148700
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0164
Number of shares heldCurrentQuarterInstant5388556
Shareholding ratioCurrentQuarterInstant0.5953
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember600
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember9049300
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember90493
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember1100
Number of shares issued shares voting rightsCurrentQuarterInstant9051000
Number of voting rights issued shares voting rightsCurrentQuarterInstant90493
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member600
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member600
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0000
Number of shares held in own name treasury shares etcCurrentQuarterInstant600
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant600
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0000
Cash and depositsPrior1YearInstant2964000000JPY
Cash and depositsCurrentQuarterInstant2942000000JPY
Accounts receivable tradePrior1YearInstant77000000JPY
Accounts receivable tradeCurrentQuarterInstant122000000JPY
Operating loans caPrior1YearInstant888000000JPY
Operating loans caCurrentQuarterInstant965000000JPY
Merchandise and finished goodsPrior1YearInstant5000000JPY
Merchandise and finished goodsCurrentQuarterInstant10000000JPY
Raw materials and suppliesPrior1YearInstant0JPY
Raw materials and suppliesCurrentQuarterInstant0JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass